Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic “mystery swine disease” and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
Type:
Grant
Filed:
January 31, 2000
Date of Patent:
June 5, 2001
Assignees:
Regents of the University of Minnesota, South Dakota State University, Boehringer Ingelheim Vetmedica, Inc.
Inventors:
James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic "mystery swine disease" and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
Type:
Grant
Filed:
September 11, 1997
Date of Patent:
August 29, 2000
Assignees:
Regents of the University of Minnesota, South Dakota State University, Boechringer Ingelheim Vetmedica, Inc.
Inventors:
James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
Abstract: The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic "mystery swine disease" and antibodies to the viral agent useful in diagnosis and treatment of MSD. The serum contains mammalian antibodies which are effective in treating MSD.
Type:
Grant
Filed:
September 30, 1994
Date of Patent:
December 8, 1998
Assignees:
Boehringer Ingelheim Animal Health, Inc., South Dakota State University, Regents of University of Minnesota
Inventors:
James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
Abstract: The method of diagnosis of Mystery Swine Disease (MSD) is carried out with polyclonal or monoclonal antibody sera. Either the antibody sera or the biopsied tissue homogenate may be immobilized by contact by contact with a polystyrene surface or with a surface of another polymer for immobilizing protein. Preferably the monoclonal antibody is produced by a murine derived hybrid cell line wherein the antibody is an IgG or IgM type immunoglobulin. Example monoclonal antibodies to the infectious agent for SIRS are monoclonal antibody SDOW 12 and SDOW 17.
Type:
Grant
Filed:
February 24, 1995
Date of Patent:
November 4, 1997
Assignees:
South Dakota State University, Regents of the University of Minnesota
Inventors:
James E. Collins, David A. Benfield, Danny W. Chladek, Louis L. Harris, David E. Gorcyca
Abstract: Monoclonal antibody sera can be produced by hybridoma technique. After immunization of a mouse, pig, rat, rabbit or other appropriate species with Mystery Swine Disease (MSD) containing cell culture lysate, the spleen of the animal can be removed and converted into a whole cell preparation. Preferably the monoclonal antibody is produced by a murine derived hybrid cell line wherein the antibody is an IgG or IgM type immunoglobulin. Example monoclonal antibodies to the infectious agent for SIRS are monoclonal antibody SDOW 12 and SDOW 17.